Linc AB (STO: LINC)

Market Cap	5.06B
Revenue (ttm)	1.56B
Net Income (ttm)	1.55B
Shares Out	57.91M
EPS (ttm)	26.83
PE Ratio	3.26
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24,408
Open	87.60
Previous Close	87.90
Day's Range	86.50 - 88.20
52-Week Range	52.20 - 103.40
Beta	1.03
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 18, 2024

About Linc AB

Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and operational companies. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million ($2.99 million) and SEK 250 million ($29.9...

• Industry: Asset Management
• Sector: Financials
• Founded: 1991
• Employees: 2
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: LINC